Effective AI governance practices play a pivotal role in promoting responsible AI adoption, extending beyond an organization’s internal policies. This presentation examines the intricate interplay between innovation and responsibility in the context of AI integration within the pharmaceutical sector. By exploring governance strategies, ethical considerations, and regulatory landscapes, we aim to equip stakeholders with the knowledge and strategies to balance effective oversight and maximize the benefits of AI in drug discovery and healthcare.
Learning Objectives:
Analyze the ethical considerations associated with AI-driven advancements in pharmaceuticals.
Evaluate current regulatory frameworks shaping the governance of AI in drug discovery and development.
Strategize approaches for effective AI governance to mitigate risk and foster responsible AI practices for vendors and users alike.
